Help us: Donate
Follow us on:
×

Menu

Back

Category: Journal Club

Journal Club
The Journal Club returns May 31st at 12:00 Eastern live on the Lifespan.io Facebook page. Dr. Oliver Medvedik will be exploring a recent paper where researchers showed that transfering fecal microbiota from young to old mice reversed some aspects of aging. Abstract Altered intestinal microbiota composition in later life is associated with infammaging, declining tissue...
Journal Club
Journal Club returns on Tuesday, April 26th at noon Eastern time on our Facebook page. Dr. Oliver Medvedik will be taking a look at the recent paper 'The hyperfunction theory: an emerging paradigm for the biology of aging'. This episode sees us taking a dive into the world of aging theory and a look at...
On Tuesday, March 29th, the Journal Club will be livestreamed to our Facebook page at 12:00 Eastern. Dr. Oliver Medvedik will be taking a look at a new paper showing that partial cellular reprogramming to reverse cellular aging in possible in normally aged mice. Previous studies demonstrated that the approach was possible in mice engineered...
Journal Club
The Journal Club returns on February 22nd at 12 PM Eastern time / 5 PM UK and will be broadcast live to our Facebook page. This month Dr. Oliver Medvedik will be taking a look at a new method of partial cellular reprogramming using the gene editing tool CRISPR. This is a particularly exciting development...
Hosted by Dr. Oliver Medvedik, Journal Club returns on Tuesday 25th January at 12:00 Eastern and will be broadcast live on the Lifespan.io Facebook page. The topic for this month is the paper 'CAR T cells produced in vivo to treat cardiac injury', which looks at how researchers created CAR T cells to target scar...
Journal Club
Journal Club with Dr. Oliver Medvedik will return on November 23rd at 12:00 Eastern live on our Facebook page. A new study appears to have solved the mystery of how amyloid beta, a key player in Alzheimer’s, forms in brain nerve cells. The data suggests that the sigma-1 receptor may be a therapeutic target for...